CVS Health CEO David Joyner Addresses Future Corporate Split Amid Ongoing Criticism
CVS Health CEO David Joyner has indicated that the company's planned structural reorganization, scheduled for the first half of 2028, is unlikely to resolve ongoing political and public criticism. The strategic move involves splitting the corporation into two distinct entities: one focused on healthcare solutions and another dedicated to retail pharmacy and community healthcare. The restructuring aims to streamline operations and potentially unlock shareholder value by separating high-growth healthcare services from the traditional retail model. However, Joyner acknowledged that even with this separation, the company will likely continue to face scrutiny regarding its role in the broader healthcare landscape.
Tickers: $CVS
Topics: corporate restructuring healthcare policy retail pharmacy